Status:
COMPLETED
Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors
Lead Sponsor:
PHCC LP
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
19-80 years
Phase:
PHASE2
Brief Summary
High blood pressure and high cholesterol are both causes of cardiovascular disease (CVD), and it is important for people with these conditions to adhere to their medication regimens. This study will e...
Detailed Description
CVD is a disorder that affects the heart's ability to function normally. The most common cause of CVD is narrowing or blockage of the coronary arteries, which supply blood to the heart. There are many...
Eligibility Criteria
Inclusion
- Prescribed one or more antihypertensive and/or lipid management medications
- Living independently
- Has a literacy level that will enable them to successfully navigate the MAS and read associated reports (i.e., approximately a sixth grade reading level)
Exclusion
- Current substance use or abuse
- Recent (in the 6 months before study entry) heart attack, stroke, peripheral vascular disease, or other medical condition that limits a potential participant's ability to complete the necessary visits to the outpatient clinic site, to use the MAS, and to complete study assessments
- Residing in assisted living or a nursing home situation
- Medical condition for which survival is expected to be unlikely in the 1 year after study entry
- Unable to read or use a computer with a computer mouse
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
308 Patients enrolled
Trial Details
Trial ID
NCT00796172
Start Date
December 1 2008
End Date
June 1 2010
Last Update
April 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PHCC LP
Pueblo, Colorado, United States, 81003